author-photo

Jaume Puig-Junoy

Pompeu Fabra University

158

Papers

3046

Citations

Citation Trend

Filter By

Papers (114) Sort By

Journal Conference Others

Inequity and benefit incidence analysis in healthcare use among Syrian refugees in Egypt.

2021 Conflict and Health
- Hani Fares
- Jaume Puig-Junoy
Show All
- Source
- Cite
- Save
Citations (0)
The Effect of Changes in Cost Sharing on the Consumption of Prescription and Over-the-Counter Medicines in Catalonia

2021 International Journal of Environmental Research and Public Health
Show All
- Source
- Cite
- Save
Citations (0)
The impact of taxing sugar-sweetened beverages on cola purchasing in Catalonia: an approach to causal inference with time series cross-sectional data

2020 European Journal of Health Economics
Show All
- Source
- Cite
- Save
Citations (2)
Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD

2020 International Journal of Chronic Obstructive Pulmonary Disease
Show All
- Source
- Cite
- Save
Citations (4)
Effectiveness and cost-effectiveness of Improving clinicians' diagnostic and communication Skills on Antibiotic prescribing Appropriateness in patients with acute Cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial.

2019 Trials
Show All
- Source
- Cite
- Save
Citations (3)
Authors’ Reply to Angelis and Kanavos: “Does MCDA Trump CEA?”

2019 Applied Health Economics and Health Policy
Show All
- Source
- Cite
- Save
Citations (0)
Post-discharge impact and cost-consequence analysis of prehabilitation in high-risk patients undergoing major abdominal surgery: secondary results from a randomised controlled trial

2019 BJA: British Journal of Anaesthesia
Show All
- Source
- Cite
- Save
Citations (28)
Clinical and economic impact of an improvement in adherence based on specific attributes of single-inhaler triple therapies in COPD patients

2019 European Respiratory Journal
Show All
- Source
- Cite
- Save
Citations (0)
Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review

2018 Expert Review of Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (11)
Non-healthcare costs of hepatitis C: a systematic review

2018 Expert Review of Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (9)